Monash Health and SMICS lead a project to improve testicular cancer survivorship care

The Testicular Cancer Survivorship project from Monash Health and SMICS aims to optimise long-term follow-up care.

Testicular cancer is the most common cancer affecting young men aged 18 to 39 years. Advances in detection and treatment have significantly improved survival rates. However, long-term health consequences and survivorship challenges are now emerging as critical concerns.

Aims of the project

Monash Health currently faces fragmented communication between oncology services, patients, and primary care, along with limited access to survivorship resources and low engagement from this young, niche group. The project also aims to educate both clinicians and patients on survivorship risks and evidence-based strategies for proactive care.

Specifically to;

• To improve adherence to testicular cancer follow‑up guidelines and the identification of psychosocial issues in patients with localised testicular cancer
• Increase the proportion of on‑time visits with correct investigations
• Identify all patients more than one month overdue for appointments
• Collect local data on relapse, adherence to guidelines, and psychosocial support.

An update on the project was recently presented on 26 February 2026 at the Cancer Survivorship Community of Practice event. Click the video below to watch the recording.

This project aligns with international best practices and focuses on prevention, recurrence surveillance, and management of treatment-related complications. It is supported by the Southern Melbourne Integrated Cancer Service (SMICS) and is funded as part of the VICS Cancer Survivorship Program.

The VICS have funded 14 such projects across Victoria to help health services respond to the long-term health and wellbeing needs of cancer survivors: Explore the projects here.